The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mattes Glenn R. since 2013.
This trader's CIK number is 1568678.
At the time of last reporting, Mattes Glenn R. was the President and CEO of Tff Pharmaceuticals, Inc.. (stock ticker symbol TFFP).
Also see all insider trading activities at Tff Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | TFFP | 16,000 | $76,480 | 0 | $0 | 0 | $0 |
2021 | TFFP | 10,000 | $71,000 | 133,000 | $2,276,200 | 130,000 | $325,000 |
2020 | TFFP | 0 | $0 | 138,830 | $2,091,805 | 138,830 | $347,075 |
2019 | TFFP | 10,000 | $50,000 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | ARNI | 20,833 | $0 | 0 | $0 | 0 | $0 |
1. Tff Pharmaceuticals, Inc. (TFFP)
2. Arno Therapeutics, Inc (ARNI)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-05-16 | TFFP | Buy | 16,000 | 4.78 | 76,480 |
2021-09-16 | TFFP | Buy | 10,000 | 7.10 | 71,000 |
2021-03-15 | TFFP | Option Ex | 50,000 | 2.50 | 125,000 |
2021-03-15 | TFFP | Sale | 50,000 | 17.04 | 852,000 |
2021-02-16 | TFFP | Sale | 40,000 | 16.82 | 672,800 |
2021-02-16 | TFFP | Option Ex | 40,000 | 2.50 | 100,000 |
2020-09-25 | TFFP | Sale | 3,000 | 17.00 | 51,000 |
2021-01-15 | TFFP | Option Ex | 40,000 | 2.50 | 100,000 |
2021-01-15 | TFFP | Sale | 40,000 | 17.51 | 700,400 |
2020-12-23 | TFFP | Option Ex | 30,000 | 2.50 | 75,000 |
2020-12-23 | TFFP | Sale | 30,000 | 15.33 | 459,900 |
2020-11-10 | TFFP | Sale | 108,830 | 14.99 | 1,631,905 |
2020-11-10 | TFFP | Option Ex | 108,830 | 2.50 | 272,075 |
2019-10-25 | TFFP | Buy | 10,000 | 5.00 | 50,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-10-29 | ARNI | Buy | 20,833 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mattes Glenn R. (President and CEO of Tff Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.